Market Research Logo

Facilities Market Research Reports & Industry Analysis

Find comprehensive market research and company reports on the Healthcare facilities Industry. More specifically, find reports on the hospice, hospitals, laboratories and assisted living markets.
...Show More ...Show Less


Facilities Industry Research & Market Reports

  • Global Drug of Abuse Testing Market (By Product Type, Sample/Test Type, End Users / Setting Type, Region), Regulatory Status, 20 Company Profile – Forecast to 2024

    ... projected to cross US$ 5 Billion by 2024. Drugs of abuse testing involves detection of one or more illegal and/or prescribed substances in the urine, blood, saliva, hair, or sweat. The use of illicit drugs ... Read More

  • Middle East And North Africa Pharmaceuticals & Healthcare Q4 2018

    ... opportunities for multinational drugmakers looking to expand to emergingmarkets. Heightened industry and country risk dissuade company interest and the larger markets dominate multinational activityfor patented medicine sales. Ample opportunities exist in the generics market segment. Read More

  • Ghana Pharmaceuticals & Healthcare Q4 2018

    ... has led to difficulties doingbusiness, including high operational costs for foreign companies. While Ghana is positioned as one of the more attractivepharmaceutical markets for multinational firms on a regional basis, generic products will maintain a ... Read More

  • Europe Pharmaceuticals & Healthcare Q4 2018

    ... to region-specific trends. Themore developed Western markets will continue to be favoured by innovative drugmakers due to stronger regulatory oversight andgreater purchasing power, although growth in these markets will be suppressed by aggressive cost-containment. Revenue ... Read More

  • Costa Rica Pharmaceuticals & Healthcare Q4 2018

    ... offers superior market access and development opportunities to multinationals based on factorssuch as continuous improvement in healthcare infrastructure and government commitment to upholding an attractive businessenvironment. Additionally, the demand for innovative medicines will still need ... Read More

  • Hong Kong Pharmaceuticals & Healthcare Q4 2018

    ... cope with a rapidly ageing population. On the private side too, the government has beenpromoting the development of private hospitals as part of its reform initiatives to improve the long-term sustainability of thecountry’s healthcare system. Read More

  • Sub-Saharan Africa Pharmaceuticals & Healthcare Q4 2018

    ... within the generic medicines sector, while the larger, moredeveloped markets present viable opportunities for patented medicine sales in urban regions. Cooperative agreements withinternational firms will provide opportunities for domestic firms to expand their manufacturing capacities. Read More

  • Asia Pharmaceuticals & Healthcare Q4 2018

    ... However, these markets will no longer providesignificant revenue growth due to aggressive cost-containment. Instead, growth opportunities will be plentiful in emerging markets.We note that due to continued regulatory challenges and a growing focus on cost-efficiency, ... Read More

  • Germany Pharmaceuticals & Healthcare Q4 2018

    ... to services, will continue tosupport this potential. However, we do caution that market access is now challenging, as authorities use a range of cost-containment measures and downward price pressures as a means of controlling state ... Read More

  • Uganda Pharmaceuticals & Healthcare Q4 2018

    ... remain dominant, while the government plans to localisedrug production to boost medicine sustainability. While the market has brighter long-term prospects, multinational drugmakerappetite will remain subdued despite the positive economic growth forecast over the coming years. Read More

  • Nicaragua Pharmaceuticals & Healthcare Q4 2018

    ... pharmaceutical companies operating in thecountry. Furthermore, the ongoing political crisis and heightened social unrest will exacerbate the risks associated with Nicaragua,further deterring multinational drugmakers from investing in what is already one of the least attractive ... Read More

  • El Salvador Pharmaceuticals & Healthcare Q4 2018

    ... for pharmaceutical investment. Despite this, a steady number ofcollaborations with international organisations and businesses is improving the standard of healthcare and raising the long-termgrowth prospects of the country's low penetration of pharmaceuticals and medical equipment. Read More

  • Mental Health & Substance Abuse Services

    ... include Acadia Healthcare, Hazelden Betty Ford Foundation, and Spectrum Health Systems (all based in the US), along with the Centre for Addiction and Mental Health (Canada), and the Crossroads Centre (Antigua). COMPETITIVE LANDSCAPE Demand for ... Read More

  • Global Drug of Abuse Testing Market (By Product Type, Sample/Test Type, End Users / Setting Type, Region), Regulatory Status, 20 Company Profile – Forecast to 2024

    ... projected to cross US$ 5 Billion by 2024. Drugs of abuse testing involves detection of one or more illegal and/or prescribed substances in the urine, blood, saliva, hair, or sweat. The use of illicit drugs ... Read More

  • SCIO Health Analytics - Strategic SWOT Analysis Review

    ... key employees, key competitors and major products and services. This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better. Scope ... Read More

  • Catholic Medical Center - Strategic SWOT Analysis Review

    ... key employees, key competitors and major products and services. This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better. Scope ... Read More

  • Namibia Pharmaceuticals & Healthcare Q4 2018

    ... and efficiency issues within the public healthcare sector. The small middle-and upper-class segments provide pockets of demand for innovative medicines, which will continue to be imported by key regionalplayers and representative offices of established multinationals. Read More

  • Panama Pharmaceuticals & Healthcare Q4 2018

    ... system inefficiencies will continueto weigh on the country’s ability to improve access to healthcare. Sustained pro-growth economic policies and the Panama Canalwill continue to support the country’s position as a logistic and export hub, including ... Read More

  • Azerbaijan Pharmaceuticals & Healthcare Q4 2018

    ... pharmaceutical market, we remain cautious about its commercial attractiveness to multinationals, at least in theshort term. The over-reliance on out-of-pocket payments has made the market vulnerable to economic fluctuations, especiallygiven its reliance on imported medicines. Read More

  • Austria Pharmaceuticals & Healthcare Q4 2018

    ... sizecompared to its EU partners. However, like its eurozone neighbours, we believe Austria's pharmaceutical spending will be subduedover the medium term, as states scramble to contain rising pharmaceutical expenditure in line with increasing healthcare demands. Read More

  • Myanmar Pharmaceuticals & Healthcare Q4 2018

    ... underdeveloped state of the public health sector will shape commercialopportunities for private healthcare providers. Despite this, the upcoming rollout of universal healthcare coverage will improve long-term opportunities for investment in Myanmar’s pharmaceutical and healthcare sectors. Read More

  • Pakistan Pharmaceuticals & Healthcare Q4 2018

    ... especially in light of the uncertainpolicy directions. In addition, the Pakistan-Tehreek-e-Insaf (PTI) political party is expected to upscale health coverage, increase thenumber of emergency units and generally implement programmes to improve health outcomes. Furthermore, the ... Read More

  • Slovakia Pharmaceuticals & Healthcare Q4 2018

    ... be driven bygovernment plans to improving access to health services with hospital reforms and diseases prevention programs. However, thegovernment’s implementation of cost-containment measures and the growing use of generic medicines will limit opportunities forinnovative drugmakers. Read More

  • Gabon Pharmaceuticals & Healthcare Q4 2018

    ... by factors including modest but growingpopulation numbers, high prevalence of infectious diseases and the growing burden of civilisation diseases. However, given thetight funding environment, most of the commercial opportunities remain limited to the generics sector. Read More

  • Tunisia Pharmaceuticals & Healthcare Q4 2018

    ... will challenge foreign investment into the sector.Highlighting the market's longer-term potential, some multinational drugmakers have shown their willingness to do business in thecountry, though the majority choose to operate indirectly to minimise the risks involved. Read More

< prev 1 3 4 5 6 7 8 9 10